
New risk assessment tools/models for suicide in people with schizophrenia and a separate one people with bipolar disorder. Developed in a national cohort in Sweden, externally validated in Finland. With a net benefit analysis - for the first time that addresses key evidence gap
In our latest paper (w/ @seenafazel & @RongqinYu), we have redeveloped the Oxford Mental Illness and Suicide tool (OxMIS) as diagnosis-specific models for schizophrenia-spectrum disorders (n = 48 373) and bipolar disorder (n = 61 684) using nationwide Swedish data, and validated them externally in equivalent data from Finland (n = 52 117 and 30 444, respectively). Discrimination was moderate for schizophrenia-spectrum disorders and good for bipolar disorder, calibration was generally good, and both models showed greater net benefit than treat-all or treat-none strategies at lower risk thresholds. Interestingly, we did not find that adding sociodemographic predictors improved predictive performance. Full-text: mentalhealth.bmj.com/content…
















